Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Avidity Biosciences Says FDA Grants Fast Track Designation To AOC 1001 For Treatment Of Myotonic Dystrophy Type 1


RTTNews | Oct 18, 2021 09:06AM EDT

09:06 Monday, October 18, 2021 (RTTNews) - Avidity Biosciences Says FDA Grants Fast Track Designation To AOC 1001 For Treatment Of Myotonic Dystrophy Type 1

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC